Drug Type Small molecule drug |
Synonyms- |
Action antagonists, agonists |
Mechanism CB1 antagonists(Cannabinoid CB1 receptor antagonists), Nicotinic receptors agonists, nAChRα4&β2 agonists(Neuronal acetylcholine receptor; alpha4/beta2 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Molecular FormulaC22H21Cl3N4O |
InChIKeyJZCPYUJPEARBJL-UHFFFAOYSA-N |
CAS Registry168273-06-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Smoking Cessation | Phase 1 | France | - | - |
Tobacco Use Disorder | Phase 1 | - | - |